{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T04:38:17Z","timestamp":1793248697350,"version":"4.5.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T00:00:00Z","timestamp":1684368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T00:00:00Z","timestamp":1684368000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81903085"],"award-info":[{"award-number":["81903085"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82073114"],"award-info":[{"award-number":["82073114"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81930086"],"award-info":[{"award-number":["81930086"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Discov."],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Cancer-testis genes are involved in the occurrence and development of cancer, but the role of cancer-testis-associated lncRNAs (CT-lncRNAs) in hepatocellular carcinoma (HCC) remains to be explored. Here, we discovered a novel CT-lncRNA, LINC01977, based on the Genotype-Tissue Expression (GTEx) and The Cancer Genome Atlas (TCGA) databases. LINC01977 was exclusively expressed in testes and highly expressed in HCC. High LINC01977 levels correlated with poorer overall survival (OS) in individuals with HCC. Functional assays showed that LINC01977 promoted HCC growth and metastasis in vitro and in vivo. Mechanistically, LINC01977 directly bound to RBM39 to promote the further entry of Notch2 into the nucleus, thereby preventing the ubiquitination and degradation of Notch2. Furthermore, the RNA binding protein IGF2BP2, one of the m<jats:sup>6<\/jats:sup>A modification readers, enhanced the stability of LINC01977, resulting in its high level in HCC. Therefore, the data suggest that LINC01977 interacts with RBM39 and promotes the progression of HCC by inhibiting Notch2 ubiquitination and degradation, indicating that LINC01977 may be a potential biomarker and therapeutic target for HCC patients.<\/jats:p>","DOI":"10.1038\/s41420-023-01459-1","type":"journal-article","created":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T03:24:33Z","timestamp":1684380273000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["The cancer-testis lncRNA LINC01977 promotes HCC progression by interacting with RBM39 to prevent Notch2 ubiquitination"],"prefix":"10.1038","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9459-0886","authenticated-orcid":false,"given":"Anliang","family":"Xia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingming","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianbo","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhangding","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongda","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1090-2174","authenticated-orcid":false,"given":"Qiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5415-7391","authenticated-orcid":false,"given":"Shouyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8657-7024","authenticated-orcid":false,"given":"Beicheng","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,18]]},"reference":[{"key":"1459_CR1","doi-asserted-by":"crossref","unstructured":"Johnson P, Zhou Q, Dao DY, Lo YMD. Circulating biomarkers in the diagnosis and management of hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol. 2022;19:670\u201381.","DOI":"10.1038\/s41575-022-00620-y"},{"key":"1459_CR2","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: Cancer J Clin. 2021;71:209\u201349.","journal-title":"CA: Cancer J Clin"},{"key":"1459_CR3","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41572-020-00240-3","volume":"7","author":"JM Llovet","year":"2021","unstructured":"Llovet JM, Kelley RK, Villanueva A, Singal AG, Pikarsky E, Roayaie S, et al. Hepatocellular carcinoma. Nat Rev Dis Primers. 2021;7:6.","journal-title":"Nat Rev Dis Primers"},{"key":"1459_CR4","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1158\/2159-8290.CD-21-1022","volume":"12","author":"B Hu","year":"2022","unstructured":"Hu B, Yu M, Ma X, Sun J, Liu C, Wang C, et al. IFNalpha potentiates anti-PD-1 efficacy by remodeling glucose metabolism in the hepatocellular carcinoma microenvironment. Cancer Discov. 2022;12:1718\u201341.","journal-title":"Cancer Discov"},{"key":"1459_CR5","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41571-021-00573-2","volume":"19","author":"JM Llovet","year":"2022","unstructured":"Llovet JM, Castet F, Heikenwalder M, Maini MK, Mazzaferro V, Pinato DJ, et al. Immunotherapies for hepatocellular carcinoma. Nat Rev Clin Oncol. 2022;19:151\u201372.","journal-title":"Nat Rev Clin Oncol"},{"key":"1459_CR6","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.cell.2016.11.037","volume":"168","author":"AW Lambert","year":"2017","unstructured":"Lambert AW, Pattabiraman DR, Weinberg RA. Emerging biological principles of metastasis. Cell. 2017;168:670\u201391.","journal-title":"Cell"},{"key":"1459_CR7","doi-asserted-by":"crossref","unstructured":"Yoo S, Kim JY, Lim YS, Han S, Choi J. Impact of HBsAg seroclearance on late recurrence of hepatitis B virus-related hepatocellular carcinoma after surgical resection. J Hepatol. 2022;77:939\u201346.","DOI":"10.1016\/j.jhep.2022.05.014"},{"key":"1459_CR8","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.jhep.2021.09.034","volume":"76","author":"A Beaufrere","year":"2022","unstructured":"Beaufrere A, Caruso S, Calderaro J, Pote N, Bijot JC, Couchy G, et al. Gene expression signature as a surrogate marker of microvascular invasion on routine hepatocellular carcinoma biopsies. J Hepatol. 2022;76:343\u201352.","journal-title":"J Hepatol"},{"key":"1459_CR9","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1038\/nrc1669","volume":"5","author":"AJ Simpson","year":"2005","unstructured":"Simpson AJ, Caballero OL, Jungbluth A, Chen YT, Old LJ. Cancer\/testis antigens, gametogenesis and cancer. Nat Rev Cancer. 2005;5:615\u201325.","journal-title":"Nat Rev Cancer"},{"key":"1459_CR10","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.trecan.2018.08.005","volume":"4","author":"ZA Gibbs","year":"2018","unstructured":"Gibbs ZA, Whitehurst AW. Emerging contributions of cancer\/testis antigens to neoplastic behaviors. Trends Cancer. 2018;4:701\u201312.","journal-title":"Trends Cancer"},{"key":"1459_CR11","doi-asserted-by":"crossref","unstructured":"Ramchatesingh B, Gantchev J, Villarreal AM, Gill RPK, Lambert M, Sivachandran S, et al. The contributions of cancer-testis and developmental genes to the pathogenesis of keratinocyte carcinomas. Cancers. 2022;14:3630.","DOI":"10.3390\/cancers14153630"},{"key":"1459_CR12","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.semcancer.2018.08.006","volume":"53","author":"O Gordeeva","year":"2018","unstructured":"Gordeeva O. Cancer-testis antigens: unique cancer stem cell biomarkers and targets for cancer therapy. Semin Cancer Biol. 2018;53:75\u201389.","journal-title":"Semin Cancer Biol"},{"key":"1459_CR13","doi-asserted-by":"publisher","first-page":"e004713.","DOI":"10.1136\/jitc-2022-004713","volume":"10","author":"Q Li","year":"2022","unstructured":"Li Q, Hu W, Liao B, Song C, Li L. Natural high-avidity T-cell receptor efficiently mediates regression of cancer\/testis antigen 83 positive common solid cancers. J Immunother Cancer. 2022;10:e004713.","journal-title":"J Immunother Cancer"},{"key":"1459_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms10499","volume":"7","author":"C Wang","year":"2016","unstructured":"Wang C, Gu Y, Zhang K, Xie K, Zhu M, Dai N, et al. Systematic identification of genes with a cancer-testis expression pattern in 19 cancer types. Nat Commun. 2016;7:10499.","journal-title":"Nat Commun"},{"key":"1459_CR15","doi-asserted-by":"publisher","first-page":"2380","DOI":"10.1016\/j.cmet.2021.11.011","volume":"33","author":"MK Park","year":"2021","unstructured":"Park MK, Zhang L, Min KW, Cho JH, Yeh CC, Moon H, et al. NEAT1 is essential for metabolic changes that promote breast cancer growth and metastasis. Cell Metab. 2021;33:2380\u201397.e2389.","journal-title":"Cell Metab"},{"key":"1459_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-31574-z","volume":"13","author":"J Bartl","year":"2022","unstructured":"Bartl J, Zanini M, Bernardi F, Forget A, Blumel L, Talbot J, et al. The HHIP-AS1 lncRNA promotes tumorigenicity through stabilization of dynein complex 1 in human SHH-driven tumors. Nat Commun. 2022;13:4061.","journal-title":"Nat Commun"},{"key":"1459_CR17","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s13045-022-01306-3","volume":"15","author":"HY Chen","year":"2022","unstructured":"Chen HY, Chan SJ, Liu X, Wei AC, Jian RI, Huang KW, et al. Long noncoding RNA Smyca coactivates TGF-beta\/Smad and Myc pathways to drive tumor progression. J Hematol Oncol. 2022;15:85.","journal-title":"J Hematol Oncol"},{"key":"1459_CR18","doi-asserted-by":"publisher","first-page":"e2201889.","DOI":"10.1002\/advs.202201889","volume":"9","author":"Q Wang","year":"2022","unstructured":"Wang Q, Chen C, Xu X, Shu C, Cao C, Wang Z, et al. APAF1-binding long noncoding RNA promotes tumor growth and multidrug resistance in gastric cancer by blocking apoptosome assembly. Adv Sci. 2022;9:e2201889.","journal-title":"Adv Sci"},{"key":"1459_CR19","doi-asserted-by":"crossref","unstructured":"Shaath H, Vishnubalaji R, Elango R, Kardousha A, Islam Z, Qureshi R, et al. Long non-coding RNA and RNA-binding protein interactions in cancer: experimental and machine learning approaches. Semin Cancer Biol. 2022;86(Pt 3):325\u201345.","DOI":"10.1016\/j.semcancer.2022.05.013"},{"key":"1459_CR20","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1038\/s41388-018-0548-x","volume":"38","author":"C Wang","year":"2019","unstructured":"Wang C, Gu Y, Zhang E, Zhang K, Qin N, Dai J, et al. A cancer-testis non-coding RNA LIN28B-AS1 activates driver gene LIN28B by interacting with IGF2BP1 in lung adenocarcinoma. Oncogene. 2019;38:1611\u201324.","journal-title":"Oncogene"},{"key":"1459_CR21","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1016\/j.cell.2017.11.040","volume":"171","author":"Y Hosono","year":"2017","unstructured":"Hosono Y, Niknafs YS, Prensner JR, Iyer MK, Dhanasekaran SM, Mehra R, et al. Oncogenic Role of THOR, a conserved cancer\/testis long non-coding RNA. Cell. 2017;171:1559\u201372.e1520.","journal-title":"Cell"},{"key":"1459_CR22","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s43018-021-00315-4","volume":"3","author":"A Xia","year":"2022","unstructured":"Xia A, Yuan W, Wang Q, Xu J, Gu Y, Zhang L, et al. The cancer-testis lncRNA lnc-CTHCC promotes hepatocellular carcinogenesis by binding hnRNP K and activating YAP1 transcription. Nat Cancer. 2022;3:203\u201318.","journal-title":"Nat Cancer"},{"key":"1459_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.canlet.2019.12.032","volume":"473","author":"J Xu","year":"2020","unstructured":"Xu J, Lu Y, Liu Q, Xia A, Zhao J, Xu X, et al. Long noncoding RNA GMAN promotes hepatocellular carcinoma progression by interacting with eIF4B. Cancer Lett. 2020;473:1\u201312.","journal-title":"Cancer Lett"},{"key":"1459_CR24","doi-asserted-by":"publisher","first-page":"e2105077","DOI":"10.1002\/advs.202105077","volume":"9","author":"M Zhou","year":"2022","unstructured":"Zhou M, Dong J, Huang J, Ye W, Zheng Z, Huang K, et al. Chitosan-gelatin-EGCG nanoparticle-meditated LncRNA TMEM44-AS1 silencing to activate the P53 signaling pathway for the synergistic reversal of 5-FU resistance in gastric cancer. Adv Sci. 2022;9:e2105077.","journal-title":"Adv Sci"},{"key":"1459_CR25","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.ccell.2019.01.010","volume":"35","author":"E Wang","year":"2019","unstructured":"Wang E, Lu SX, Pastore A, Chen X, Imig J, Chun-Wei Lee S, et al. Targeting an RNA-binding protein network in acute myeloid leukemia. Cancer Cell. 2019;35:369\u201384.e367.","journal-title":"Cancer Cell"},{"key":"1459_CR26","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1038\/s41586-021-03222-x","volume":"591","author":"D Sharma","year":"2021","unstructured":"Sharma D, Zagore LL, Brister MM, Ye X, Crespo-Hernandez CE, Licatalosi DD, et al. The kinetic landscape of an RNA-binding protein in cells. Nature. 2021;591:152\u20136.","journal-title":"Nature"},{"key":"1459_CR27","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/s41576-020-00302-y","volume":"22","author":"F Gebauer","year":"2021","unstructured":"Gebauer F, Schwarzl T, Valcarcel J, Hentze MW. RNA-binding proteins in human genetic disease. Nat Rev Genet. 2021;22:185\u201398.","journal-title":"Nat Rev Genet"},{"key":"1459_CR28","doi-asserted-by":"publisher","first-page":"8207","DOI":"10.1093\/nar\/gkac605","volume":"50","author":"N Mestre-Farras","year":"2022","unstructured":"Mestre-Farras N, Guerrero S, Bley N, Rivero E, Coll O, Borras E, et al. Melanoma RBPome identification reveals PDIA6 as an unconventional RNA-binding protein involved in metastasis. Nucleic Acids Res. 2022;50:8207\u201325.","journal-title":"Nucleic Acids Res"},{"key":"1459_CR29","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.3324\/haematol.2019.218289","volume":"105","author":"J Tong","year":"2020","unstructured":"Tong J, Xu X, Zhang Z, Ma C, Xiang R, Liu J, et al. Hypoxia-induced long non-coding RNA DARS-AS1 regulates RBM39 stability to promote myeloma malignancy. Haematologica. 2020;105:1630\u201340.","journal-title":"Haematologica"},{"key":"1459_CR30","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/s41420-021-00598-7","volume":"7","author":"C Xu","year":"2021","unstructured":"Xu C, Chen X, Zhang X, Zhao D, Dou Z, Xie X, et al. RNA-binding protein 39: a promising therapeutic target for cancer. Cell Death Discov. 2021;7:214.","journal-title":"Cell Death Discov"},{"key":"1459_CR31","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/j.ccell.2018.07.009","volume":"34","author":"O Meurette","year":"2018","unstructured":"Meurette O, Mehlen P. Notch signaling in the tumor microenvironment. Cancer Cell. 2018;34:536\u201348.","journal-title":"Cancer Cell"},{"key":"1459_CR32","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1038\/s41388-019-1075-0","volume":"39","author":"C Guan","year":"2020","unstructured":"Guan C, He L, Chang Z, Gu X, Liang J, Liu R. ZNF774 is a potent suppressor of hepatocarcinogenesis through dampening the NOTCH2 signaling. Oncogene. 2020;39:1665\u201380.","journal-title":"Oncogene"},{"key":"1459_CR33","doi-asserted-by":"publisher","first-page":"4061","DOI":"10.1038\/s41388-019-0704-y","volume":"38","author":"S Fang","year":"2019","unstructured":"Fang S, Liu M, Li L, Zhang FF, Li Y, Yan Q, et al. Lymphoid enhancer-binding factor-1 promotes stemness and poor differentiation of hepatocellular carcinoma by directly activating the NOTCH pathway. Oncogene. 2019;38:4061\u201374.","journal-title":"Oncogene"},{"key":"1459_CR34","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/s41419-018-0554-5","volume":"9","author":"G Huang","year":"2018","unstructured":"Huang G, Jiang H, Lin Y, Wu Y, Cai W, Shi B, et al. lncAKHE enhances cell growth and migration in hepatocellular carcinoma via activation of NOTCH2 signaling. Cell Death Dis. 2018;9:487.","journal-title":"Cell Death Dis"},{"key":"1459_CR35","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s13045-022-01304-5","volume":"15","author":"F Zhang","year":"2022","unstructured":"Zhang F, Liu H, Duan M, Wang G, Zhang Z, Wang Y, et al. Crosstalk among m(6)A RNA methylation, hypoxia and metabolic reprogramming in TME: from immunosuppressive microenvironment to clinical application. J Hematol Oncol. 2022;15:84.","journal-title":"J Hematol Oncol"},{"key":"1459_CR36","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1038\/s41392-022-01003-0","volume":"7","author":"C Xue","year":"2022","unstructured":"Xue C, Chu Q, Zheng Q, Jiang S, Bao Z, Su Y, et al. Role of main RNA modifications in cancer: N(6)-methyladenosine, 5-methylcytosine, and pseudouridine. Signal Transduct Target Ther. 2022;7:142.","journal-title":"Signal Transduct Target Ther"},{"key":"1459_CR37","doi-asserted-by":"publisher","first-page":"3368","DOI":"10.1016\/j.molcel.2021.07.024","volume":"81","author":"JH Lee","year":"2021","unstructured":"Lee JH, Wang R, Xiong F, Krakowiak J, Liao Z, Nguyen PT, et al. Enhancer RNA m6A methylation facilitates transcriptional condensate formation and gene activation. Mol Cell. 2021;81:3368\u201385.e3369.","journal-title":"Mol Cell"},{"key":"1459_CR38","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1136\/gutjnl-2019-319639","volume":"69","author":"Q Wang","year":"2020","unstructured":"Wang Q, Chen C, Ding Q, Zhao Y, Wang Z, Chen J, et al. METTL3-mediated m(6)A modification of HDGF mRNA promotes gastric cancer progression and has prognostic significance. Gut. 2020;69:1193\u2013205.","journal-title":"Gut"},{"key":"1459_CR39","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13045-020-00895-1","volume":"13","author":"Q Wang","year":"2020","unstructured":"Wang Q, Geng W, Guo H, Wang Z, Xu K, Chen C, et al. Emerging role of RNA methyltransferase METTL3 in gastrointestinal cancer. J Hematol Oncol. 2020;13:57.","journal-title":"J Hematol Oncol"},{"key":"1459_CR40","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1016\/j.ccell.2021.04.017","volume":"39","author":"Y Cheng","year":"2021","unstructured":"Cheng Y, Xie W, Pickering BF, Chu KL, Savino AM, Yang X, et al. N(6)-Methyladenosine on mRNA facilitates a phase-separated nuclear body that suppresses myeloid leukemic differentiation. Cancer Cell. 2021;39:958\u201372.e958.","journal-title":"Cancer Cell"},{"key":"1459_CR41","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/s41556-018-0045-z","volume":"20","author":"H Huang","year":"2018","unstructured":"Huang H, Weng H, Sun W, Qin X, Shi H, Wu H, et al. Recognition of RNA N(6)-methyladenosine by IGF2BP proteins enhances mRNA stability and translation. Nat Cell Biol. 2018;20:285\u201395.","journal-title":"Nat Cell Biol"},{"key":"1459_CR42","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.stem.2021.09.014","volume":"29","author":"R Yin","year":"2022","unstructured":"Yin R, Chang J, Li Y, Gao Z, Qiu Q, Wang Q, et al. Differential m(6)A RNA landscapes across hematopoiesis reveal a role for IGF2BP2 in preserving hematopoietic stem cell function. Cell Stem Cell. 2022;29:149\u201359.e147.","journal-title":"Cell Stem Cell"}],"container-title":["Cell Death Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41420-023-01459-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41420-023-01459-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41420-023-01459-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T03:25:24Z","timestamp":1684380324000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41420-023-01459-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,18]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1459"],"URL":"https:\/\/doi.org\/10.1038\/s41420-023-01459-1","relation":{},"ISSN":["2058-7716"],"issn-type":[{"value":"2058-7716","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,18]]},"assertion":[{"value":"5 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"169"}}